N/A
N=551
Evaluation of an Automated Physician-Directed Messaging on Patient Engagement in the Digital Diabetes Prevention Program
Pre Diabetes
Bottom Line
View on ClinicalTrials.gov: NCT04773834 ↗Enrolled (actual)
551
Serious AEs
0.0%
Results posted
Jan 2026
Primary outcome: Primary: Change in Hemoglobin A1c (HbA1c) Level (mmol/Mol) — 0.02; -0.03 mmol/mol
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Digital diabetes prevention program (dDPP) (Other); Adapted dDPP-EHR tool (Other)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- NYU Langone Health
- Primary completion
- Jan 2025
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Change in Hemoglobin A1c (HbA1c) Level (mmol/Mol) |
0.01; 0.01 | — |
| PRIMARY Change in Hemoglobin A1c (HbA1c) Level (mmol/Mol) |
0.01; 0.01 | — |
| PRIMARY Change in Body Weight (Lbs) |
-7.42; -7.02 | — |
| PRIMARY Change in Body Weight (Lbs) |
-7.42; -7.02 | — |
| PRIMARY Change in Body Mass Index (BMI) (Lbs/in^2) |
1.2045; -1.16 | — |
| PRIMARY Change in Body Mass Index (BMI) (Lbs/in^2) |
1.2045; -1.16 | — |
| SECONDARY Engagement With the dDPP Platform |
0.29; 0.25 | — |
| SECONDARY Engagement With the dDPP Platform |
0.29; 0.25 | — |
Summary
This study aims to understand the effects of automated physician directed messaging on patient engagement in the digital diabetes prevention program (dDPP). The messages are tailored to patient engagement levels based on established engagement thresholds, which are based on the patient's use of the dDPP application. The system is designed to minimize work for providers by sending automated targeted messages to patients to potentially increase engagement, prevent onset of diabetes and improve clinical outcomes. The patients in the study are automatically nudged using a combination of text messaging and MyChart messaging.
Eligibility Criteria
Inclusion Criteria
- 18 years or older, BMI ≥ 25 kg/m2 (> 22 kg/m2 if self-identified as Asian)
- Must be a NYU Langone patient
- A diagnosis of prediabetes (either diagnosis of prediabetes or an HbA1C level of 5.7%-6.4% in past 12 months) or diabetes risk factors (BMI ≥ 25 kg/m2 or > 22 kg/m2 if self-identified as Asian
- Safe to engage in moderate physical exercise (as determined by their PCP)
- Sufficient English to be able to complete the enrollment process
- Has app-capable device with data to use the dDPP application and receive text messages
Exclusion Criteria
- Diagnosed with diabetes
- Patients whose weight may vary considerably over the study's timeframe for reasons other than the intervention (e.g. cancer, pregnancy, ascites, severe CHF)
- Patients with severe psychiatric disease or dementia
- Active health condition that prevents them from engaging in moderate exercise
Data sourced from ClinicalTrials.gov (NCT04773834). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.